7/29/2019 Clinical Trial Protocol
1/21
N`mcmnf` Urmf` Zratana`
7/29/2019 Clinical Trial Protocol
2/21
Ua fcswor f n`mcmnf` prai`odUa gfmc cow kcaw`oego fiaut f cow ar ostfi`msh
troftdoct
Ua suppart f n`fmd-lar gfmcmcg gavorcdoct rogu`ftary fppravf`
-lar dfrkotmcg f erug, eovmno, ar tonhcmquo
Why ea f n`mcmnf` trmf`1
7/29/2019 Clinical Trial Protocol
3/21
F n`mcmnf` trmf` pratana` nactfmcs f stuey p`fc ac whmnh tho n`mcmnf`
ifsoe
MNH gumeo`mcos stfto2
F eanudoct thft eosnrmios tho aibontmvo(s), eosmgc, dothaea`agy
nacsmeorftmacs fce argfcmzftmac al f trmf`
Uho pratana` usuf``y f`sa gmvos tho ifnkgrauce fce rofsac tho trm
naceuntoe, iut thoso nau`e io pravmeoe mc athor eanudocts rolo
tho pratana` (sunh fs fc mcvostmgftars iranhuro).
Whft ms f pratana`1
7/29/2019 Clinical Trial Protocol
4/21
Mcstrunts stuey tofd ac oxfnt`y whft ta ea
Oxp`fmcs tho stuey ta tho autsmeo war`e
Zravmeos f rovmowfi`o eanudoct lar
conossfry fppravf`s
whft ms tho purpaso1
7/29/2019 Clinical Trial Protocol
5/21
Othmns
^nmoctmlmn vf`memty fce mctogrmty
Doemnf` ro`ovfcno
Yogu`ftary fce doemna `ogf` mssuos
Nasts
Gumemcg prmcnmp`os
7/29/2019 Clinical Trial Protocol
6/21
aMctraeuntmac fce rftmacf`o
a
^tuey aibontmvos2 prmdfry fce sonacefryaAvorf`` stuey eosmgc
a^tuey l`aw shoot
aOcra``doct nrmtormf
a^ponmlmn stuey pranoeuros
aYfceadmzftmac
aMctorvoctmacaAutnado dofsurodocts
aZratana` eovmftmacs
aEftf fcf`ysms fce stftmstmns
aOthmnf` nacsmeorftmacs (Eon`frftmac al Ho`smckm)
Fcftady al f typmnf` stuey pratana
7/29/2019 Clinical Trial Protocol
7/21
O`odoct Zurpaso6. Yosofrnh quostmacs Whft quostmacs wm`` tho stuey feeross19. mgcmlmnfcno (ifnkgrauce) Why fro thoso quostmacs mdpartfct1>. Eosmgc
Umdo lrfdoOpmeodma`agmn fpprafnh
Haw ms tho stuey strunturoe1
5. ^uibonts
^o`ontmac nrmtormf^fdp`mcg eosmgc
Wha fro tho suibonts fce haw wm`` thoy i
?. \frmfi`os
Zroemntar vfrmfi`osNaclaucemcg vfrmfi`osAutnado vfrmfi`os
Whft dofsurodocts wm`` io dfeo1
7/29/2019 Clinical Trial Protocol
8/21
Dfbar hofemcgs mc f pratanaUmt`o
Mcvostmgftars, mcstmtutmacf` fllm`mftmacs, & quf`mlmnftmacs
^uddfry/Fistrfnt
6. Mctraeuntmac
@mtorfturo rovmow; Datmvftmac lar tho stuey (prai`od); Zurpaso; ponmlmn aibontmvos; Mdp`odo
9. Dothaes
Eolmcmtmac al tords; tuey eosmgc; tuey papu`ftmac fce sfdp`mcg; Dofsurodocts; Zm`at stue
>. @agmstmns fce tmdo snhoeu`o
Yospacsmim`mtmos al mcvostmgftars fce al stfll; Umdo snhoeu`o
5. Eftf dfcfgodoct fce fcf`ysms
?. Yosaurnos
Fvfm`fi`o rosaurnos; Iuegot fce iuegot datmvftmac
7/29/2019 Clinical Trial Protocol
9/21
Nadpacocts al f rosofrnh prapaF. Umt`o pfgoI. Ufi`o al nactocts
N. FistrfntE. Zrabont Eosnrmptmac
6. Mctraeuntmac9. Zrai`od stftodoct fce smgcmlmnfcno>. Gaf`s fce aibontmvos5. Dothaes fce pranoeuros
?. Ovf`uftmac
7/29/2019 Clinical Trial Protocol
10/21
Dfmc pratana` o`odocts
Uho fiavo pratana` aut`mcos hfvo thoso fs dfmc o`od
Zapu`ftmac
Vuostmac
Yo`ovfcno
^tuey eosmgc fce vfrmfi`os Umdolrfdo
Ua uceorstfce thoso, wo cooe ta rovmsmt sadoopmeodma`agy
7/29/2019 Clinical Trial Protocol
11/21
Umt`o pfgo2
Zratana` tmt`o, pratana` meoctmlymcg cudior fce efto. Fcy fdoced
shau`e f`sa iofr tho fdocedoct cudior(s) fce efto(s).
Cfdo fce feeross al tho spacsar fce dacmtar(ml athor thfc tho sp
Naclmeoctmf`mty stftodoct
Ufi`o al nactocts
Ofsy rolorocno taa`
Gocorf` mclardftmac
7/29/2019 Clinical Trial Protocol
12/21
Uypmnf` Mcn`usmac nrmtormf
^uibont dust hfvo emsofso al mctorost
^uibont dust hfvo f nortfmc fdauct al emsofso
^uibont dust uceorstfce stuey fce fgroo ta pfrtmnmpf
Athor
Uypmnf` oxn`usmac nrmtormf
^uibont dust cat io ac fc fntmvo troftdoct
^uibont dust cat io f``orgmn ta mctorvoctmac
Zrogcfcny, irofstlooemcg nhm`e
Athor
7/29/2019 Clinical Trial Protocol
13/21
^uibont mcn`usmac nrmtormf.
^uibont oxn`usmac nrmtormf.
^uibont wmtherfwf` nrmtormf (m.o., tordmcftmcg mcvostmgftmacf` praeunt troft
troftdoct) fce pranoeuros sponmlymcg2
(f) Whoc fce haw ta wmtherfw suibonts lrad tho trmf`/ mcvostmgftmacf` prae
troftdoct.
(i) Uho typo fce tmdmcg al tho eftf ta io na``ontoe lar wmtherfwc suibonts.
(n) Whothor fce haw suibonts fro ta io rop`fnoe.
(e) Uho la``aw-up lar suibonts wmtherfwc lrad mcvostmgftmacf` praeunt trof
troftdoct.
7/29/2019 Clinical Trial Protocol
14/21
7/29/2019 Clinical Trial Protocol
15/21
7.Fssossdoct al Ollmnfny
^ponmlmnftmac al tho ollmnfny pfrfdotors.
Dothaes fce tmdmcg lar fssossmcg, ronaremcg, fce fcf`yzmcg ollmnfny pfr
8. Fssossdoct al ^floty
^ponmlmnftmac al sfloty pfrfdotors.
Uho dothaes fce tmdmcg lar fssossmcg, ronaremcg, fce fcf`yzmcg sfloty
pfrfdotors.Zranoeuros lar o`mnmtmcg roparts al fce lar ronaremcg fce ropartmcg fevo
fce mctornurroct m``cossos.
Uho typo fce eurftmac al tho la``awup al suibonts fltor fevorso ovoc
7/29/2019 Clinical Trial Protocol
16/21
=. ^tftmstmns
_soe ta eotordmco tho smgcmlmnfcno al tho stuey eftf ifsoe ac `fws al prF`sa usoe ta eotordmco tho pawor al f stuey (m.o. cudior al pftmocts cooe
ronrumt)
F eosnrmptmac al tho stftmstmnf` dothaes ta io odp`ayoe, Mcn`uemcg tmdmcg
p`fccoe mctormd fcf`ysms.
Uho cudior al suibonts p`fccoe ta io ocra``oe. Mc du`tmnoctor trmf`s, tho
ocra``oe suibonts prabontoe lar ofnh trmf` smto shau`e io sponmlmoe.Yofsac lar nhamno al sfdp`o smzo, mcn`uemcg rol`ontmacs ac tho pawor al th
n`mcmnf` bustmlmnftmac.
Nrmtormf lar tho tordmcftmac al tho trmf`.
Zranoeuro lar fnnauctmcg lar dmssmcg, ucusoe, fce spurmaus eftf.
7/29/2019 Clinical Trial Protocol
17/21
Zranoeuros lar ropartmcg fcy eovmftmac(s) lrad tho armgmcf` stftmstmnf` p`f
eovmftmac(s) lrad tho armgmcf` stftmstmnf` p`fc shau`e io eosnrmioe fce bust
pratana` fce/ar mc tho lmcf` ropart, fs fppraprmfto).
Uho so`ontmac al suibonts ta io mcn`ueoe mc tho fcf`ysos (o.g.. f`` rfcead
f`` easoe suibonts, f`` o`mgmi`o suibonts, ovf`uftofi`o suibonts).
7/29/2019 Clinical Trial Protocol
18/21
6:. Emront Fnnoss ta ^aurno Eftf Eanudocts
Uho spacsar shau`e ocsuro thft mt ms sponmlmoe mc tho pratana` ar athor wr
fgroodoct thft tho mcvostmgftar(s)/mcstmtutmac(s) wm`` pordmt trmf`- ro`ftoe
fuemts, MYI/MON rovmow, fce rogu`ftary mcspontmac(s) iy pravmemcg emront f
saurno eftf/eanudocts.
66. Vuf`mty Nactra` fce Vuf`mty Fssurfcno
7/29/2019 Clinical Trial Protocol
19/21
69. Othmns
Eosnrmptmac al othmnf` nacsmeorftmacs ro`ftmcg ta tho trmf`.
6>. Eftf Hfce`mcg fce Yonarekoopmcg
65. Lmcfcnmcg fce Mcsurfcno
Lmcfcnmcg fce mcsurfcno fro feerossoe mc f sopfrfto fgroodoc
7/29/2019 Clinical Trial Protocol
20/21
6?. Zui`mnftmac Za`mnyZui`mnftmac pa`mny, ml cat feerossoe mc f sopfrfto fgroodoct.
6
7/29/2019 Clinical Trial Protocol
21/21